May 2, 2007 – TeraRecon announced yesterday the availability of its time-intensity analysis tools for Breast MRI studies as a standard feature on its industry-leading AquariusNET thin-client server, with advanced pre-processing options available for the recently introduced AquariusAPS server.

When using the AquariusNET software, Regions of Interest (ROI) can be defined and plots generated showing time-dependent behavior. For a scan where a lesion enhances and then de- enhances over time, the analysis tool plots a curve showing the characteristics of temporal behavior in that ROI.

When using AquariusAPS, the optional “Parametric Maps” module can be automatically applied to datasets to obtain automatic registration and subtraction of the data, followed by color-map encoding of each pixel according to its temporal behavior. This color overlay can assist physicians in assessing tissue characteristics at a glance. Physicians can import, access, and display these large multi-phase datasets from regular PCs using the AquariusNET thin-client software. The software can display breast MRI studies in a fully volumetric view in any oblique plane desired as well as side-by-side, multi-phase, and 4D double oblique views with localized measurement capabilities. With this import and display feature, outside examinations on digital media from any institution can be easily compared.

The American Cancer Society (ACS) has recently announced new cancer screening guidelines for women at different defined levels of risk of developing breast cancer. According to the ACS statement, screening MRI is recommended for women with an approximately 20-25 percent or greater lifetime risk of breast cancer, including women with a strong family history of breast or ovarian cancer and women who were treated for Hodgkin disease.


Related Content

News | Radiology Business

April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time April 04, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | FDA

March 27, 2024 — SyntheticMR announced that its next-generation imaging solution, SyMRI 3D, has received FDA 510(k) ...

Time March 27, 2024
arrow
News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | Cardiac Imaging

February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...

Time February 12, 2024
arrow
News | Radiology Business

January 25, 2024 — Esaote Group, a leading Italian innovator in medical imaging, today unveiled its new brand identity ...

Time January 25, 2024
arrow
News | Artificial Intelligence

January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
arrow
News | Artificial Intelligence

December 22, 2023 — Quibim, a company pioneering imaging biomarkers for Precision Medicine that has created AI-based ...

Time December 22, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

December 20, 2023 — Terran Biosciences, Inc., a biotech platform company developing therapeutics and technologies for ...

Time December 20, 2023
arrow
News | Radiopharmaceuticals and Tracers

December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...

Time December 06, 2023
arrow
Subscribe Now